Pharmaceutical salts, J. Pharm. Sci, vol.66, pp.1-19, 1977. ,
Anilide and cyclodextrin complexes, their preparation and their use as medicine in particular for treating dyslipidemiae, 2002. ,
Microbroyage et dissolution, S.T.P. Pharma, vol.1, pp.296-299, 1985. ,
Melt extrusion: from process to drug delivery technology, Eur. J. Pharm. Biopharm, vol.54, pp.107-117, 2002. ,
La biodisponibilité des principes actifs par inclusion dans les cyclodextrines, S.T.P. Pharma, vol.1, pp.323-332, 1985. ,
Determination of the stoichiometry of 2,4-dichlorophenoxyacetic acid-?-cyclodextrin complexes in solution and solid state, Thermochim. Acta, vol.321, pp.53-58, 1998. ,
Solid-state microcalorimetry on drug-cyclodextrin binary systems, J. Therm. Anal, vol.38, pp.2683-2691, 1992. ,
Inclusion complex formation of acetominophen by heating and cogrinding with cyclodextrins, J. Incl. Phenom. Mol. Recognit. Chem, vol.14, pp.149-156, 1992. ,
Avoiding investment in doomed drugs, is poor solubility an industry wide problem? Curr. Drug Dis, pp.17-19, 2001. ,
Poor aqueous solubility-an industry wide problem in drug discovery, Am. Pharm. Rev, vol.5, pp.82-85, 2002. ,
Pharmaceutical applications of cyclodextrins, J. Pharm. Sci, vol.85, pp.1017-1025, 1996. ,
Nanosizing: a formulation approach for poorly-water-soluble compounds, Eur. J. Pharm. Sci, vol.18, pp.113-120, 2003. ,
Biopharmaceutics and pharmacokinetics in drug research, Int. J. Pharm, vol.201, pp.131-150, 2000. ,
5-trimethyl-4-hydroxyanilide derivatives, preparation thereof and therapeutical use thereof, vol.2, 1997. ,